Professor, Medicine, USC School of Medicine
Cardiology
Dr. Robert A. Kloner, MD
|
|
Give Review
Doctor Robert A. Kloner, MD works in the field of Cardiology. He studied medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care He over the years received 2 awards: "Elected Member" and "Fellow (FACC)". Dr. Robert A. Kloner has written publications. He has 101 publications published with PubMed. The lastest paper is: 'Testosterone and Cardiovascular Disease.'
Publications
- Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted Heart.
- EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary pe...
- New therapies for reducing post-myocardial left ventricular remodeling.
- Hypothermia in the Setting of Experimental Acute Myocardial Infarction: A Comprehensive Review.
- Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and Arrhythmias in experimental models.
- Bendavia, a mitochondria-targeting peptide, improves post-infarction cardiac function, prevents adverse left ventricular remodeling and restores mitochondria-related g...
- Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion.
- Rapid Induction of Hypothermia by the ThermoSuit System Profoundly Reduces Infarct Size and Anatomic Zone of No Reflow Following Ischemia-Reperfusion in Rabbit and Rat...
- Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy.
- Capsaicin-Induced Cardioprotection. Is Hypothermia or the Salvage Kinase Pathway Involved?
- Combined Remote Perconditioning and Postconditioning Failed to Attenuate Infarct Size and Contractile Dysfunction in a Rat Model of Coronary Artery Occlusion.
- The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction.
- Super Bowl outcome's association with cardiovascular death.
- Reduction of Early Reperfusion Injury With the Mitochondria-Targeting Peptide Bendavia.
- Efficacy and safety of ranolazine in patients with chronic stable angina.
- Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know.
- Remote ischemic preconditioning for coronary artery bypass graft operations.
- Current state of clinical translation of cardioprotective agents for acute myocardial infarction.
- Can myocardial infarct size be reduced by mechanically unloading the left ventricle?
- Role of Protein Kinase C in Ischemic "Conditioning": From First Evidence to Current Perspectives.
- A brief review of useful tips for publishing your scientific manuscript.
- Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of in...
- Sexual Function in Patients With Chronic Angina Pectoris.
- Delayed treatment with hypothermia protects against the no-reflow phenomenon despite Failure to reduce infarct size.
- Intramyocardial Injection of Heart Tissue-Derived Extracellular Matrix Improves Postinfarction Cardiac Function in Rats.
- Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk.
- Schwartz et Al reply.
- Devices to treat peripheral chronic total occlusions.
- Emotional stressors trigger cardiovascular events.
- The Effect of Acute Versus Delayed Remote Ischemic Preconditioning on Reperfusion Induced Ventricular Arrhythmias.
- Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.
- Treating peripheral arterial Disease percutaneously with atherectomy.
- Therapeutic Hypothermia for Acute Myocardial Infarction and Cardiac Arrest.
- Unusual Substrate Underlying Brugada Syndrome and Early Repolarization Syndrome Revealed in Unusual Circadian and Seasonal Patterns.
- Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned?
- Cardiac uses of phosphodiesterase-5 inhibitors.
- High-Risk Percutaneous Coronary Intervention with the TandemHeart and Impella Devices: A Single-Center Experience.
- New horizons in cardioprotection: recommendations from the 2010 national Heart, lung, and blood institute workshop.
- State of the Science of Cardioprotection: Challenges and Opportunities-- Proceedings of the 2010 NHLBI Workshop on Cardioprotection.
- Introduction to Proceedings of the NHLBI Workshop: New Horizons in Cardioprotection--A Focused Issue of Journal of Cardiovascular Pharmacology and Therapeutics.
- No-reflow phenomenon: maintaining vascular integrity.
- Protecting the Heart from ischemia: an update on ischemic and pharmacologic conditioning.
- Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms?
- Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
- Author's Reply:.
- Coronary no reflow.
- Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical application.
- First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
- Cardiovascular implications of erectile dysfunction.
- Rotational atherectomy in the drug-eluting stent era: a single-center experience.
- Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
- The combined administration of multiple soluble factors in the repair of chronically infarcted rat myocardium.
- Role of age, sex, and race on cardiac and total mortality associated with Super Bowl wins and losses.
- Clinical cardiology: physician update: erectile dysfunction and cardiovascular Disease.
- Left ventricular remodeling in the post-infarction Heart: a review of cellular, molecular mechanisms, and therapeutic modalities.
- Cardiovascular effects of cocaine.
- Effects of zoledronate in the repair of chronically infarcted rat myocardium.
- Review of vascular closure devices.
- Sporting events affect spectators' cardiovascular mortality: it is not just a game.
- Diannexin Reduces No-Reflow after Reperfusion in Rabbits with Large Ischemic Myocardial Risk Zones.
- No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy.
- When and why do Heart attacks occur? Cardiovascular triggers and their potential role.
- Influenza-related viral myocarditis.
- Comparison of automated oscillometric versus auscultatory blood pressure measurement.
- The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular Arrhythmias: through a mechanism favoring inhibition of late sodium channel.
- Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary Hypertension.
- Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
- Experimental cell transplantation therapy in rat myocardial infarction model including nude rat preparation.
- Ranolazine, an antianginal agent, markedly reduces ventricular Arrhythmias induced by ischemia and ischemia-reperfusion.
- Particulate air pollution and coronary heart Disease.
- Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat Hearts.
- Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy.
- A salute to our founding editor-in-chief Bramah N. Singh, MD, DPhil, DSc, FRCP.
- Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device.
- Comparison of total and cardiovascular death rates in the same city during a losing versus winning super bowl championship.
- Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application.
- The mechanism by which ischemic postconditioning reduces reperfusion Arrhythmias in rats remains elusive.
- Real-time intravascular shear stress in the rabbit abdominal aorta.
- Complication rate of diagnostic carotid angiography performed by interventional cardiologists.
- Clinical application of remote ischemic preconditioning.
- Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy.
- Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
- Direct and acute cardiotoxic effects of ultrafine air pollutants in spontaneously hypertensive rats and Wistar--Kyoto rats.
- The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in t...
- Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms.
- New insights into the open artery hypothesis.
- Ischemic postconditioning's benefit on reperfusion ventricular Arrhythmias is maintained in the senescent heart.
- Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient.
- Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.
- Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
- Preconditioning in humans.
- Office evaluation of male sexual dysfunction.
- Case studies: applying JNC-7 treatment guidelines.
- Cocaine-induced acute myocardial infarction.
- To drink or not to drink? That is the question.
- Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices.
- Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model.
- Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: a pilot study.
- ACCF/AHA/CDC Conference report on emerging infectious Diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biolog...
- Testosterone and Cardiovascular Disease.
Schools
Northwestern Center Feinberg School of Medicine
Conditions Treated
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Congestive Heart Failure
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Northwestern University Feinberg School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Anil K. Bhandari, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Damon M. Kwan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yzhar Charuzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameer Amin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reza Arsanjani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Cassidy, MD |
|
|
Dr. Ali Nsair, MD |